
Mikasafe 500mg Injection
Marketer
S R Pharmaceuticals
Salt Composition
Amikacin (500mg)
Overview Mikasafe 500mg Injection
Cefamox 500mg Injection is a broad-spectrum antibiotic combating diverse bacterial infections. These encompass urinary tract, bone, joint, pulmonary (including pneumonia), central nervous system, and bloodstream infections. Prophylactic use is also indicated in hospitalized individuals. Cefamox 500mg Injection inhibits bacterial proliferation. Administered intravenously (drip) or intramuscularly by a healthcare professional only, self-injection is strictly prohibited. Adherence to the prescribed dosage schedule is crucial; skipping doses or prematurely halting treatment may result in infection recurrence or exacerbation. Commonly reported adverse effects include injection site inflammation and elevated blood urea nitrogen. Persistent side effects or treatment inefficacy necessitate immediate medical consultation. High-dose therapy may exceptionally induce vertigo, nephrotoxicity, and ototoxicity. Consequently, meticulous adherence to physician instructions is mandatory, potentially including regular assessments of renal function, auditory acuity, and urinalysis. This medication is contraindicated in pregnancy. Disclose pregnancy, pregnancy intentions, or breastfeeding to your physician.
Uses of Mikasafe 500mg Injection
Infections caused by bacteria
Major Benefits of Mikasafe 500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Mikasafe 500mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Mikasafe 500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Mikasafe 500mg Injection works:
Mikasafe 500mg Injection, an antibacterial medication, inhibits bacterial proliferation by disrupting the production of proteins crucial for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
The concurrent use of Mikasafe 500mg Injection and alcohol does not produce adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Mikasafe 500mg Injection during pregnancy poses a confirmed risk to the fetus and is therefore contraindicated. Exceptions may exist in critical medical circumstances where a physician deems the potential benefits outweigh the inherent dangers. Physician consultation is mandatory.
Breast feedingSAFE IF PRESCRIBED
Administering Mikasafe 500mg Injection while breastfeeding is considered safe. Research in humans indicates negligible transfer of the medication into breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
Administration of Mikasafe 500mg Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Exercise caution when administering Mikasafe 500mg Injection to individuals with impaired renal function. Dosage modification for Mikasafe 500mg Injection may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Mikasafe 500mg Injection appears to pose minimal risk for individuals with hepatic impairment. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Mikasafe 500mg Injection :
Omit a Mikasafe 500mg Injection dose? Seek medical advice immediately.
Facts to Know About Mikasafe 500mg Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Action class | Aminoglycoside antibiotics |
